Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
Alnylam Pharmaceuticals Inc (NASDAQ: ALNY) closed the day trading at $267.55 up 0.26% from the previous closing price of $266.86. In other words, the price has increased by $0.26 from its previous closing price. On the day, 0.7 million shares were traded. ALNY stock price reached its highest trading level at $270.0 during the session, while it also had its lowest trading level at $261.85.
Ratios:
For a better understanding of ALNY, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.98 and its Current Ratio is at 3.04. In the meantime, Its Debt-to-Equity ratio is 23.58 whereas as Long-Term Debt/Eq ratio is at 22.47.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Redburn Atlantic on March 31, 2025, initiated with a Buy rating and assigned the stock a target price of $353.
On March 24, 2025, JP Morgan Upgraded its rating to Overweight which previously was Neutral and also upped its target price recommendation from $280 to $328.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 29 ’24 when Reitan Colleen F bought 32 shares for $286.00 per share. The transaction valued at 9,152 led to the insider holds 32 shares of the business.
Reitan Colleen F bought 4 shares of ALNY for $1,211 on Oct 17 ’24. The Director now owns 36 shares after completing the transaction at $302.67 per share. On Apr 16 ’25, another insider, Reitan Colleen F, who serves as the Director of the company, sold 36 shares for $232.86 each. As a result, the insider received 8,383 and left with 0 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALNY now has a Market Capitalization of 34885308416 and an Enterprise Value of 34975444992. For the stock, the TTM Price-to-Sale (P/S) ratio is 14.86 while its Price-to-Book (P/B) ratio in mrq is 302.03. Its current Enterprise Value per Revenue stands at 14.895 whereas that against EBITDA is -604.955.
Stock Price History:
The Beta on a monthly basis for ALNY is 0.16, which has changed by 0.7692765 over the last 52 weeks, in comparison to a change of 0.11241627 over the same period for the S&P500. Over the past 52 weeks, ALNY has reached a high of $304.39, while it has fallen to a 52-week low of $144.73. The 50-Day Moving Average of the stock is 5.93%, while the 200-Day Moving Average is calculated to be 2.93%.
Shares Statistics:
Over the past 3-months, ALNY traded about 988.81K shares per day on average, while over the past 10 days, ALNY traded about 1084690 shares per day. A total of 130.31M shares are outstanding, with a floating share count of 124.69M. Insiders hold about 4.37% of the company’s shares, while institutions hold 95.48% stake in the company. Shares short for ALNY as of 1745971200 were 3149449 with a Short Ratio of 3.19, compared to 1743379200 on 2989679. Therefore, it implies a Short% of Shares Outstanding of 3149449 and a Short% of Float of 3.19.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
